Results 191 to 200 of about 45,170 (239)

Neuraminidase and tumor immunotherapy

Klinische Wochenschrift, 1977
Preliminary results of first clinical studies with the enzyme neuraminidase call attention to a new kind of cancer treatment. This promising approach to tumor immunotherapy was entered into the clinical phase as a consequence of successful experimental studies in tumor-bearing mice, rats and dogs.
H H, Sedlacek, F R, Seiler, H G, Schwick
openaire   +2 more sources

Isoelectric focusing of neuraminidase

Experientia, 1970
Die isoelektrischen Punkte der Neuraminidasen vonVibrio cholerae (pH 4.80) undClostridium perfringens (pH 4.95) wurden mittels isoelektrischer Fokusierung bestimmt. Neuraminidasen zwei verschiedener Influenzaviren (A2/Aichi/68 und B/Mass/66) wurden entsprechend analysiert.
A R, Neurath, R W, Hartzell, B A, Rubin
openaire   +2 more sources

Neuraminidase assays.

Developments in biologicals, 2004
Anti-neuraminidase (NA) antibodies (Ab) play a role in protection against influenza and in combination with anti-HA Ab they increase the protection in mice. To control the NA content of vaccines, which should improve vaccine standardisation and may benefit vaccine efficacy, a series of questions must be addressed: 1) The antigenic characterization of ...
M, Aymard, O, Ferraris, L, Gerentes, J, Jolly, N, Kessler   +4 more
openaire   +1 more source

Brain Neuraminidases and Gangliosides

1976
A number of data of kinetics nature indicate that brain neuraminidases (the cytosol and the membrane bound enzyme) recognize the physical state of gangliosidic substrate, with immediate modification of the activity. The interactions between the enzyme(s) and the different physical forms of the substrate are still to be studied at the molecular level ...
G, Tettamanti, B, Venerando, B, Cestaro, A, Preti   +3 more
openaire   +2 more sources

Neuraminidase Inhibitors for Influenza

New England Journal of Medicine, 2005
he impact of influenza infection is felt globally each year when the disease develops in approximately 20 percent of the world’s population. In the United States, influenza infections occur in epidemics each winter, generally between late December and early March. Recent events, including human cases of avian influenza, have heightened awareness of the
openaire   +2 more sources

Substrate specificity of neuraminidases

The Histochemical Journal, 1973
This presentation is a brief description of neuraminidases and is mainly concerned with the substrate specificity of these enzymes. From the observed great differences in substrate specificity it is clear that we are dealing not with one enzyme called neuraminidase but with a variety of enzymes named neuraminidases.
openaire   +2 more sources

Neuraminidase-Inhibition Assay for the Identification of Influenza A Virus Neuraminidase Virus Subtype or Neuraminidase Antibody Specificity

2008
The neuraminidase-inhibition (NI) assay is a laboratory procedure for the identification of the neuraminidase (NA) glycoprotein subtype in influenza viruses or the NA subtype specificity of antibodies to influenza virus. A serological procedure for subtyping the NA glycoprotein is critical for the identification and classification of avian influenza ...
openaire   +3 more sources

[Neuraminidase inhibitor].

Nihon rinsho. Japanese journal of clinical medicine, 2001
Amantadine, effective to influenza A virus, is now widely used in Japan. Recently new anti-influenzal agents, neuramidase inhibitor has been developed. Both Zanamivir (inhaled type) and Oseltamivir(oral use), are proved to be effective in treatment of influenza A and B.
openaire   +1 more source

Neuraminidase inhibitors for influenza

BMJ, 2014
The whole truth and nothing but the truth Informed choice requires comprehensive and credible information. Much of the rationale for the currently evolving movement to fully share data is to provide information for decision making, particularly in situations involving the need to balance the potential benefits and harms of medical products.
openaire   +2 more sources

Extracellular Streptococcal Neuraminidase

Journal of Bacteriology, 1968
J K, Pinter, J A, Hayashi, A N, Bahn
openaire   +2 more sources